Suppr超能文献

根据皮下低分子肝素给药持续时间出现瘀伤的情况和程度:一项准实验性病例交叉研究。

Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study.

机构信息

School of Nursing, Udine University, Italy.

出版信息

J Cardiovasc Nurs. 2013 Sep-Oct;28(5):473-82. doi: 10.1097/JCN.0b013e3182578b87.

Abstract

BACKGROUND

Several authors have documented the role of low-molecular-weight heparin injection techniques in bruising. However, few researchers have measured the influence of injection duration on the occurrence and extent of bruising.

PURPOSE

The aim of this study was to evaluate the influence of different durations of subcutaneous heparin injection on the occurrence and extent of bruising.

METHODS

A quasi-experimental case-crossover study design was adopted in 2010. A consecutive series of patients admitted to 2 orthopedic units in a large (600 beds) teaching hospital located in northern Italy were eligible for enrolment. Injections were administered following a standard procedure. The manipulated variable was the duration of the injection, 10 seconds (treatment A) and 30 seconds (treatment B). The evaluation of bruise occurrence and extension performed after 48 hours and data analysis were conducted in a blinded fashion.

RESULTS

A total of 150 patients receiving their first and second subcutaneous heparin injections (300 injections) were enrolled. Eighty-seven bruises were observed out of 300 injections (29%): 57 of 150 (38%) after injections lasting 10 seconds and 30 of 150 (20%) after injections lasting 30 seconds (relative risk, 1.50; 95% confidence interval, 1.21-1.86; P = .00). Of the 87 bruises that occurred, 69 (79.3%) were small (2-5 mm) and 18 (20.6%) were large (>5 mm), with no difference in size between 10- and 30-second injections (relative risk, 0.91; 95% confidence interval, 0.39-2.12; P = .83).

CONCLUSIONS

Low-molecular-weight heparin injection should be administered over 30 seconds to decrease bruising.

CLINICAL IMPLICATIONS

There is a need to reflect on the feasibility of such a practice because injecting low-molecular-weight heparin at 30 seconds requires accuracy, a steady hand, the absence of tremor, a calm environment, and the ability to administer an infinitesimally small amount of liquid (eg, 0.4 mL) per second.

摘要

背景

有几位作者记录了低分子量肝素注射技术在瘀伤中的作用。然而,很少有研究人员测量注射持续时间对瘀伤发生和程度的影响。

目的

本研究旨在评估皮下肝素注射不同持续时间对瘀伤发生和程度的影响。

方法

2010 年采用准实验病例交叉设计。意大利北部一家大型(600 张床位)教学医院的 2 个骨科病房连续收治的患者符合入组条件。注射采用标准程序进行。处理变量为注射持续时间,10 秒(治疗 A)和 30 秒(治疗 B)。在 48 小时后进行瘀伤发生和延伸的评估,并进行盲法数据分析。

结果

共纳入 150 例接受首次和第二次皮下肝素注射(共 300 次注射)的患者。在 300 次注射中观察到 87 处瘀伤(29%):150 次中的 57 次(38%)注射持续 10 秒,150 次中的 30 次(20%)注射持续 30 秒(相对风险,1.50;95%置信区间,1.21-1.86;P =.00)。在发生的 87 处瘀伤中,69 处(79.3%)为小(2-5 毫米),18 处(20.6%)为大(>5 毫米),10 秒和 30 秒注射的瘀伤大小无差异(相对风险,0.91;95%置信区间,0.39-2.12;P =.83)。

结论

为减少瘀伤,应将低分子量肝素注射持续时间延长至 30 秒以上。

临床意义

需要考虑这种做法的可行性,因为在 30 秒内注射低分子量肝素需要精确、稳定的手、无震颤、平静的环境和以每秒极少量(例如 0.4 毫升)的速度给药的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验